Overview

Gap Analysis of Dossiers and Responses

Regxia’s extensive experience creating and adapting submissions for the FDA and Health Canada allows us to identify potential questions from regulatory agencies during assessment and, most importantly, pro-actively develop resolutions. Regxia is able to assess dossiers for strengths and weaknesses, regulatory authority acceptance and identify corrective measures before substantial investments have been made .

Support for Agency Meetings

On behalf of our customers, Regxia has arranged for timely meetings, prepared high-quality and effective briefing documents and provided advice on presentation content and format.

Literature Reviews to support SRTD or 505(b)(2) Applications

Regxia's team has experience conducting systematic literature reviews to support your SRTD or 505(b)(2) application.

Show More

Activity